Diabetes Wound Care and Treatment-Free-Samples-Myassignmenthelp.com

Question: Discuss about the Diabetes Wound Care and Treatment. Answer: Introduction: Wound is any type of injury sustained on a living tissue due to a blow, cut or impact, resulting in cuts or breakage of the skin. Minor wounds can naturally heal over time, however for people suffering with diabetes, the wound can take a several weeks to heal, and often can get infected. The normal wound healing process occurs in three stages, in the first stage an immune reaction causes inflammation in the wound to prevent infection, in the second stage, new cells are formed over the wound forming scab and in final stage a scar tissue develops healing the wound. The wound healing process can get delayed or complicated because of different health issues like: diabetes mellitus, rheumatoid arthritis, low levels of Human Growth Hormone, Vascular disease and zinc deficiency. Each of these factors affects the healing of wound differently. In diabetes, high levels of blood glucose can cause neuropathy (damage to nerves) and reduces blood circulation, thereby preventing blood to reach the areas affected by wounds or sores, thus affecting the normal healing process. Unhealed wounds further increases risk of infections (fungal or bacterial) and even gangrene (Ha.org.hk 2018; Mousley 2018). Problem Statement: Foot ulcers in diabetes care caused due to neuropathy, reduced blood circulation and elevated plantar pressures, higher chances of morbidity, loss of limb and even mortality (Kavitha et al. 2014). This highlights the necessity of early identification of the condition to prevent its associated risks. Studies by Hurlow et al. (2015) have suggested that the evidence of biofilms presence on slow healing wounds can be a precursor of an infection. Furthermore, biofim can have adverse effects on key healing processes like the inflammatory response of immune system, formation of granular tissue and epithelialization (Seth et al. 2012). This poses an important question can biofilm be useful in the early detection of infection in diabetic foot ulcers? Research Objectives/Questions: The objective of the research is to study whether presence of biofilm can be used for early slow healing foot ulcers in diabetic patients and what treatment/management strategies can be used to minimize the risk of morbidity and mortality due to it. Literature Review: Through a systematic review of literature, several aspects were highlighted that requires further studies to be done in the field of diabetic wound management. These aspects are arranged thematically: Biofilms: Studies by Harlow et al. (2015) suggested that slow healing wounds often develop biofilm, which can be a precursor of an infection. Biofilms can be understood as a well structured microbial community existing in a polymeric matrix that is created by the microbes (called extracellular polymeric substances EPS) stuck to a living or inert surface (Flemming et al. 2015). Seth et al. (2012) also supported that biofilm bacteria are more resistant to the immune reaction of the host as well as antiseptics and antibiotics, in comparison to planktonic bacteria, which increases the risks of wound infection. Furthermore, local inflammatory response to biofilm and microbial toxin can further cause damage to the tissues, and the biofilm can spread by seeding to adjacent surfaces to the wound, forming new microbial colonies (Philips and Schultz 2012; Kaplan, Meyenhofer and Fine 2003). Hurlow and Bowler (2012) added that poor moisture or poor control of exudates in the environment can lead to the fo rmation of a biofilm. Multispecies biofilm also have been found to be more pathogenic compared to single species biofilm (Seth et al. 2012). This further implicates the necessity to identify the type of biodiversity while analyzing risk of infection. Detecting biofim on wounds can allow healthcare providers to take precautionary steps to avoid infection before the manifestation of its clinical signs like fever, suppuration, erythema, edema, and pain in the wound, and conversely, presence of wounds that does not heal despite treatment, can suggest the presence of biofilm (Hurlow et al. 2015). Flemming et al. (2016) studied biofilms charecteristics that helps in the formation of the microbe habitat on the wound. They identified different properties like localized gradients (that provides a diversity in habitat), sorption (capture of resource by microbes), enzyme retention (that helps in external digestion), cooperation (forming a synergistic relation between the microbes), competition (that causes continuous regeneration of microbes) and tolerance (protecting the microbes from destruction). Such properties enable the sustenance of the microbial population on the biofilm. Figure 1: Emergent properties of biofilm and habitat formation; source: (Flemming et al. 2016). Visualization of biofilm can be done my different microscopy techniques like fluorescent staining with confocal microscopy; peptide nucleic acid fluorescent in situ hybridization; scanning electron microscopy and light microscopy with gram staining (Oates et al. 2014). Evidence of biofilm on clinical wounds can also be evidence by the presence of excessive and increasing fluid exudates from wound, antibiotic resistance, and repeated infection and wound recalcitrance. However, the study of literature showed a lack of detailed studies done to link the biofilms presence on diabetic foot ulcers and the rapid detection of biofilm on chronic wounds. Such knowledge can help to ascertain the importance of biofilm in wound care practices. Diabetic Foot Ulcer DFU: Diabetic Foot ulcers are linked with diabetic neuropathy and nerve pain, and can affect people suffering from both diabetes type 1 and 2. The foot ulcers can be caused due to mild injuries to the foot, which subsequently fails to heal, and cause ulcers. The risk for this condition can increase due to neuropathy, poor circulation of blood, unmanaged/untreated/uncontrolled diabetes, poor fitting footwear, walking barefoot or any activities that can increase the likelihood of sustaining even minor injury to the foot or lower extremities (Diabetes.co.uk 2018). Estimates show that the propensity of diabetic patients to develop foot ulcers can be 10%-25% (Dargaville et al. 2013). Due to the steep increase in the global diagnosis of diabetes, it is necessary that the process of chronic wound repair and tissue regeneration be studied in detail, which can help to develop understanding of the process, and implement effective strategies for management and treatment. Dreifke, Jayasuriya and Jaya suriya (2015) suggested that primary objective for healing of wound involves timely closure of wound, prompt relief in pain, and aesthetically acceptable scar. Hyperglycemia (or high blood glucose) can inhibit the formation of Extra Cellular Matrix ECM through rising secretion of Tumor Necrosis Factor TNF alpha and Interleukins IL-1beta. This is further complicated due to impaired migration of keratinocyte and function of leukocyte can lead to infection. Additionally, depletion of inorganic phosphates in the ulcerated area, leads to lowered levels of Adenosine Tri Phosphate (ATP) thereby adversely affecting the immune response, further delaying/inhibiting the natural healing process (Lev-Tov 2013). Strategies like systemic glucose control, debridement of nonviable tissue and maintaining proper perfusion of extremities are of immense importance for treating diabetic ulcers (Dreifke, Jayasuriya and Jayasuriya 2015). Moura et al. (2014) suggested chitosan (a linear copolymer extracted from the exoskeleton of crustaceans like crab or shrimps) based dressings for healing diabetic wounds. They used the substance 5-methyl-pyrolidinone chitosan (MPC) that supplies neurotensin (which is a neuropeptide that functions as inflammatory modulator), and found that it can promote healing of wound. Studies done using various forms of chitosan, like microparticles, membranes, hydrogel and scaffold to analyze their wound healing effects (Park et al. 2009). Such strategy has shown to reduce diabetic wounds in mice by 50% (Moura et al. 2014). Studies by Yao et al. (2006) showed that treating patients suffering from diabetic foot ulcers with Fibroblast Growth Factor-2 (FGF2) can increase wound closure by 68%, and in 3 weeks accelerated wound closure by 24% in comparison to a placebo group. This was further supported through studies by Singla et al. (2014) that showed a significant improvement in healing time and increase in closure of diabetic foot ulcers by the application of tropical gens containing human epidermal growth factor (EGF). Debridement (removal of damaged, dead or infected tissues) of diabetic wound has been acknowledged to improve the healing potential of the surrounding healthy tissues. Different types of debridement strategies have been suggested by many studies. Surgical debridement where the necrotic or infected tissue is surgically removed is the quickest and most efficient method (Driver 2014). In autolytic debridement, an occlusive dressing is applied on the wound that allows tissue fluids containing macrophages, enzymes and neutrophils to accumulate which can then eliminate the microbes and digest the necrotic tissues in a moist wound healing environment (Sibbald et al. 2000). Mechanical debridement requires the elimination of necrotic tissue by wound dressing that is regularly changed, without causing any damage to the adjacent healthy tissues. Scrubbing of the wounds also helps the elimination of devitalized tissue and wound exudates, however such a process can also cause bleeding and pain du e to trauma to wound (Rolstad and Ovington 2017). Enzymatic debridement involves enzymes like collagenase, papain and fibrinolysin, and can be used when surgical process is not an option (Ramundo and Gray 2008). Maggot debridement involves maggots of Lucilia sericata, raised in sterile environment, placed on the wound and then wrapped using secondary dressing. Consequently the maggot larvae feeds on the dead tissue and secrete antimicrobial substances that ultimately show infection and foster healing and closure of wound. This implicates the importance to study further how the application of chitosan, growth factors and debridement of diabetic foot ulcers can reduce associated complications, morbidity risks and accelerate the processes of healing ad closure of wound. Research Design and Methodology: The study will involve diabetes patients, who have been diagnosed with foot ulcer (DFU). The study will analyze each patient using gram staining and light microscopy and scanning electron microscopy to finds signs of biofilm and to classify its type, and then put on a treatment module that comprises of chitosan dressing and application of Growth Factors, and debridement (if needed) for 2 weeks. After the treatment, the patients will be analyzed again for foot ulcer. The study will be compared to a trial group consisting of patients with signs of biofilm, but given a different form of treatment or patients who refused treatment after diagnosis. The selected research process will be a primary research, and research philosophy will be positivism as it allows objectivity in the study, and gain factual information from the observation. The research design will be conclusive and the type of conclusive research design used will be causal as it aims to ascertain whether early detection of DFU using biofilm and early treatment can enhance wound healing and closure (that is studying the effect of early detection and treatment for DFU). The sample will be drawn from patients diagnosed with diabetes and foot ulcers (in the UK) but have not started treatment for the same. The study will exclude patients of foot ulcers from other causes (other than diabetes) to eliminate interferences in the etiologies of different conditions. Sample size: the sample can include anywhere between 20 to 30 patients (depending on the final sampling process), and will be selected through non-probability (purposive) sampling. This can be useful to analyze whether early identification of infections in diabetic foot ulcers can be done by looking for signs of biofilm on diabetic patients, and whether the selected management/treatment strategies can enhance or accelerate the healing and closure of wound. Data collection method will be quantitative, and collect the following data: Presence of Biofilm (yes/no) Type of biofilm (single species/multi species) Wound healing time after treatment (in days) Wound closing time after treatment (in days) The collected data will be subjected to correlation analysis to relate the early detection of biofilm and faster recovery due to treatment with chitosan, growth factor and debridement. Ethical Considerations: To ensure compliance to ethical standards and principles, the following ethical considerations shall prevail throughout the study: Participation of the patient in the study will be completely voluntary All participants will be briefed before and after the study, informing them about the reason for the study and the overall flow of the study or treatment Any personally identified information will be kept confidential and private, and shall not be published or shared. All clinical and diagnostic data will be represented intact, without any manipulation Permission will be taken from the local ethics board/committee before starting the research. Conclusion: Diabetic foot ulcer can increase risks of morbidity and even mortality in diabetic patients, and considering the rise in the cases of diabetes globally, it is important to learn strategies that can enable early detection and prevention of DFU and its co morbidities. Also precautionary strategies (prevention of diabetes) can be the most efficient; more studies needs to be done that can link the importance of biofilm specifically for DFU. Since biofilm have been identified as a prequel to infection, detection of biofilm on foot ulcer can be a strong suggestion for treatment measures. The study will aim to analyze how early detection coupled with prompt intervention can reduce the risks associated with DFU and allow speedy recovery. The final results of the study can then be then used to compare results from other studies to support its veracity References: Dargaville, T.R., Farrugia, B.L., Broadbent, J.A., Pace, S., Upton, Z. and Voelcker, N.H., 2013. Sensors and imaging for wound healing: a review.Biosensors and Bioelectronics,41, pp.30-42. Diabetes.co.uk, 2018.Diabetes and Foot Ulcers. [online] Diabetes.co.uk. Available at: https://www.diabetes.co.uk/diabetes-complications/diabetic-foot-ulcers.html [Accessed 23 Feb. 2018]. Dreifke, M., Jayasuriya, A. and Jayasuriya, A., 2015. Current wound healing procedures and potential care.Materials Science and Engineering: C, 48, pp.651-662. Driver, V.R., 2014. Treating the macro and micro wound environment of the diabetic patient: managing the whole patient, not the hole in the patient. InFoot and Ankle QuarterlyThe Seminar Journal(Vol. 16, pp. 47-56). Flemming, H.C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S.A. and Kjelleberg, S., 2016. Biofilms: an emergent form of bacterial life.Nature Reviews Microbiology,14(9), p.563. Ha.org.hk., 2018.Cite a Website - Cite This For Me. [online] Ha.org.hk. Available at: https://www.ha.org.hk/haho/ho/ap/AP17-18Eng.pdf [Accessed 22 Feb. 2018]. Hurlow, J. and Bowler, P.G., 2012. Potential implications of biofilm in chronic wounds: a case series.journal of wound care,21(3), pp.109-119. Hurlow, J., Couch, K., Laforet, K., Bolton, L., Metcalf, D. and Bowler, P., 2015. Clinical Biofilms: A Challenging Frontier in Wound Care.Advances in Wound Care, 4(5), pp.295-301. Kaplan, J.B., Meyenhofer, M.F. and Fine, D.H., 2003. Biofilm growth and detachment of Actinobacillus actinomycetemcomitans.Journal of bacteriology,185(4), pp.1399-1404. Kavitha, K., Tiwari, S., Purandare, V., Khedkar, S., Bhosale, S. and Unnikrishnan, A., 2014. Choice of wound care in diabetic foot ulcer: A practical approach.World Journal of Diabetes, 5(4), p.546. Lev-Tov, H., Li, C.S., Dahle, S. and Isseroff, R.R., 2013. Cellular versus acellular matrix devices in treatment of diabetic foot ulcers: study protocol for a comparative efficacy randomized controlled trial.Trials,14(1), p.8. Moura, L.I., Dias, A.M., Leal, E.C., Carvalho, L., de Sousa, H.C. and Carvalho, E., 2014. Chitosan-based dressings loaded with neurotensinAn efficient strategy to improve early diabetic wound healing.Acta biomaterialia,10(2), pp.843-857. Mousley, M., 2018.Diabetes and its effect on wound healing and patient care. [online] Nursing Times. Available at: https://www.nursingtimes.net/clinical-archive/diabetes/diabetes-and-its-effect-on-wound-healing-and-patient-care/205050.article [Accessed 23 Feb. 2018]. Oates, A., Bowling, F.L., Boulton, A.J., Bowler, P.G., Metcalf, D.G. and McBain, A.J., 2014. The visualization of biofilms in chronic diabetic foot wounds using routine diagnostic microscopy methods.Journal of diabetes research,2014. Park, C.J., Clark, S.G., Lichtensteiger, C.A., Jamison, R.D. and Johnson, A.J.W., 2009. Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF.Acta biomaterialia,5(6), pp.1926-1936. Phillips, P.L. and Schultz, G.S., 2012. Molecular mechanisms of biofilm infection: biofilm virulence factors.Advances in wound care,1(3), pp.109-114. Ramundo, J. and Gray, M., 2008. Enzymatic wound debridement.Journal of Wound Ostomy Continence Nursing,35(3), pp.273-280. Rolstad, B.S. and Ovington, L.G., 2017. Principles of wound management.Acute and chronic wounds: current management concepts,3, pp.391-426. Seth, A.K., Geringer, M.R., Hong, S.J., Leung, K.P., Galiano, R.D. and Mustoe, T.A., 2012. Comparative analysis of single-species and polybacterial wound biofilms using a quantitative, in vivo, rabbit ear model.PLoS One,7(8), p.e42897. Seth, A.K., Geringer, M.R., Hong, S.J., Leung, K.P., Mustoe, T.A. and Galiano, R.D., 2012. In vivo modeling of biofilm-infected wounds: a review.Journal of surgical research,178(1), pp.330-338. Sibbald, R.G., Williamson, D., Orsted, H.L., Campbell, K., Keast, D., Krasner, D. and Sibbald, D., 2000. Preparing the wound bed--debridement, bacterial balance, and moisture balance.Ostomy/wound management,46(11), pp.14-22. Singla, S., Garg, R., Kumar, A. and Gill, C., 2014. Efficacy of topical application of beta urogastrone (recombinant human epidermal growth factor) in Wagner's Grade 1 and 2 diabetic foot ulcers: Comparative analysis of 50 patients.Journal of natural science, biology, and medicine,5(2), p.273. Yao, C., Yao, P., Wu, H. and Zha, Z., 2006. Acceleration of wound healing in traumatic ulcers by absorbable collagen sponge containing recombinant basic fibroblast growth factor.Biomedical materials,1(1), p.33.